These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7166918)

  • 21. Isolation and characterization of two bladder carcinoma-associated antigens.
    Braesch-Andersen S; Paulie S; Koho H; Perlmann P
    J Immunol Methods; 1986 Nov; 94(1-2):145-51. PubMed ID: 3782807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Some uses and limitations of immunologic testing in human patients.
    Lavergne JA
    Bol Asoc Med P R; 1981 Apr; 73(4):141-5. PubMed ID: 6946780
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect of the serum blocking factor assay in the diagnosis and treatment of bladder cancer].
    Xu JN; Li YT; Zhang ZY
    Zhonghua Wai Ke Za Zhi; 1985 Aug; 23(8):453-6, 508. PubMed ID: 4092537
    [No Abstract]   [Full Text] [Related]  

  • 24. Expression of CD15 antigen in urinary bladder transitional cell carcinoma.
    Parham DM; Morton K; Coghill G; Robertson AJ; Kerr MA
    J Clin Pathol; 1990 Jul; 43(7):541-3. PubMed ID: 1974266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of onco-fetal bladder antigen in urine of patients with transitional cell carcinoma.
    Liu BC; Neuwirth H; Zhu LW; Stock LM; Dekernion JB; Fahey JL
    J Urol; 1987 Jun; 137(6):1258-61. PubMed ID: 3295305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunology of the bladder.
    Graham SD
    Urol Clin North Am; 1992 Aug; 19(3):541-8. PubMed ID: 1636238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Specificity of in vitro cellular cytotoxicity against transitional cell carcinoma cell line T-24.
    Catalona WJ; Oldham RK; Djeu JY; Herberman RB; Cannon GB
    Surg Forum; 1975; 26():122-4. PubMed ID: 56048
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro production of human antibodies against bladder cancer: characterization and diagnostic implications.
    Pizza G; De Vinci C
    J Exp Pathol; 1987; 3(4):335-46. PubMed ID: 2457663
    [No Abstract]   [Full Text] [Related]  

  • 29. [Studies on blood group isoantigens in the uroepithelium. II. Prognostic significance of blood group substances in tumor-bearing bladders].
    Abe R; Kato T; Mori H; Sato K; Moriyama M; Harada M
    Nihon Hinyokika Gakkai Zasshi; 1986 Mar; 77(3):482-8. PubMed ID: 3735873
    [No Abstract]   [Full Text] [Related]  

  • 30. [Antigens of the ABO blood group in the bladder urothelium: comparison of 3 technics for its detection].
    Cuadrado E; Rodríguez-Trinidad A; Blasco E; Torrado J
    Arch Esp Urol; 1985; 38(3):291-9. PubMed ID: 3904638
    [No Abstract]   [Full Text] [Related]  

  • 31. Tumor-associated and spontaneous lymphocyte-mediated cytotoxicity against cell lines derived from human urothelium.
    Vilien M
    Dan Med Bull; 1985 Aug; 32(4):199-218. PubMed ID: 3899526
    [No Abstract]   [Full Text] [Related]  

  • 32. [Expression of blood group antigens in 30 patients with transitional-cell carcinomas of the bladder].
    Vieillefond A; Quillard J; Meatchi T; Benoit G; Jardin A; Martin E
    Ann Pathol; 1987; 7(1):9-14. PubMed ID: 3620025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Monoclonal antibodies against transitional cell carcinoma assay tumor associated antigens in different grades bladder cancer patients].
    Zhang H; Zhao Z; Sun H
    Zhonghua Wai Ke Za Zhi; 1996 Sep; 34(9):560-2. PubMed ID: 9594163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal antibodies against carcinoma cells of the human urinary bladder: immunohistochemical staining of tissues.
    Ben-Aïssa H; Paulie S; Koho H; Biberfeld P; Hansson Y; Braesch-Andersen S; Lagerkvist M; Lundblad ML; Gustafson H; Perlmann P
    Anticancer Res; 1986; 6(2):165-70. PubMed ID: 2423013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunohistochemical study of tissue polypeptide antigen (TPA) in human urinary bladder tumors].
    Kaneko K; Suzuki T; Takasaki E
    Nihon Hinyokika Gakkai Zasshi; 1989 Oct; 80(10):1430-5. PubMed ID: 2601216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study of the Thomsen-Friedenreich antigen in bladder tumors].
    Fukatsu H; Yamada H; Nonomura H; Miyagawa Y; Waki M; Hatano Y; Hiraiwa S; Muramatsu T; Nishikawa E; Yamada Y
    Hinyokika Kiyo; 1988 Feb; 34(2):260-7. PubMed ID: 3376818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carcinoembryonic antigen in the urine of patients with urothelial carcinoma.
    Hall RR; Laurence DJ; Darcy D; Stevens U; James R; Roberts S; Munro Neville A
    Br Med J; 1972 Sep; 3(5827):609-11. PubMed ID: 5071696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical role of the mixed cell agglutination test in the prospective management of superficial bladder tumors.
    Johnson JD; Lamm DL; Radwin HM
    J Surg Oncol; 1980; 13(3):189-95. PubMed ID: 6990112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leukocyte migration inhibition assay in patients with bladder cancer.
    Schellhammer PF; Wright GL; Rosato FE; Faulconer RJ
    J Urol; 1979 Dec; 122(6):746-9. PubMed ID: 513216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specificities and binding properties of 2 monoclonal antibodies against carcinoma cells of the human urinary bladder.
    Ben-Aissa H; Paulie S; Koho H; Biberfeld P; Hansson Y; Lundblad ML; Gustafson H; Jonsdottir I; Perlmann P
    Br J Cancer; 1985 Jul; 52(1):65-72. PubMed ID: 4015953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.